FDA 483 - Cliantha Research Limited - April 17, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Cliantha Research Limited's Biopharmaceutics Analytical and Clinical Facility in Ahmedabad, India, revealed significant deficiencies across multiple areas. The firm failed to consistently investigate internal standard variations, maintain proper source documentation, and account for missing sample volumes. Additionally, the quality unit did not perform adequate laboratory investigations, and legally effective informed consent was not obtained from subjects.
ID · 961322eb-f7bc-44a9-919c-b35305525671